Netherlands biotech Argenx has a second FDA approval for its FcRn inhibitor Vyvgart Hytrulo, adding a new indication in chronic inflammatory demyelinating polyneuropathy (CIDP) for a drug that it ...

A chronic inflammatory demyelinating polyneuropathy (CIDP) patient registry aiming to capture longitudinal observational data on the disease is soon to launch. “Vitaccess Real CIDP (VRCIDP) is a ...

Worldwide Healthcare Trust PLC - Annual Financial Report PR Newswire LONDON, United Kingdom, June 11 10 June 2025Worldwide Healthcare Trust PLC(the "Company") Annual Financial ...

I will also consider the focal diabetic neuropathies, and discuss the diagnosis of chronic inflammatory demyelinating polyneuropathy, which should not be missed or confused with diabetic ...

systemic lupus erythematosus (SLE), idiopathic inflammatory myopathies (IIMs), chronic inflammatory demyelinating polyneuropathy (CIDP), haemolytic disease of the foetus and newborn (HFDN), warm ...

In chronic inflammatory demyelinating polyneuropathy (CIDP), intravenous immunoglobulin (IVIg) has multiple mechanisms of action that affect various components of the disease, including circulating ...

three with chronic inflammatory demyelinating polyneuropathy (CIDP), and one with HMSN III (CMT3). CONCLUSIONS Most of these syndromes were shown to be related to genetic or immunological defects of ...